Near-infrared therapy is emerging as a promising treatment for brain injuries, offering new hope for recovery by enhancing healing and reducing...
Vous n'êtes pas connecté
Brigham's dual-action treatment shows promise in preclinical lung cancer models, enhancing drug delivery and immune response.
Near-infrared therapy is emerging as a promising treatment for brain injuries, offering new hope for recovery by enhancing healing and reducing...
In drug discovery, targeted protein degradation is a method that selectively eliminates disease-causing proteins.
Immunotherapies that mobilise a patient’s immune system to fight cancer have become a treatment pillar. These therapies, including CAR T-cell...
MRK in-licenses a bispecific antibody, based on the same mechanism as SMMT's lead drug, which outperformed its blockbuster drug, Keytruda, in a lung...
Research Shows Alternative Treatment Regimens Against Drug-resistant TB With tuberculosis (TB) reemerging as the leading infectious disease killer in...
Researchers at the Icahn School of Medicine at Mount Sinai, USA, have discovered a way that ovarian cancer tumours manipulate their environment to...
Researchers at the Icahn School of Medicine at Mount Sinai, USA, have discovered a way that ovarian cancer tumours manipulate their environment to...
Discover how pembrolizumab, an immunotherapy drug, enhances disease-free survival in advanced soft tissue sarcoma, offering a promising treatment...
Discover how pembrolizumab, an immunotherapy drug, enhances disease-free survival in advanced soft tissue sarcoma, offering a promising treatment...
Columbia researchers have engineered probiotic bacteria that educate the immune system to destroy cancer cells, opening the door for a new class of...